Stockholders’ Equity (Deficit) (Details) - Schedule of the Status of our Unvested and Related Transactions - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Restricted Stock Units (RSUs) [Member]
Stockholders’ Equity (Deficit) (Details) - Schedule of the Status of our Unvested and Related Transactions [Line Items]
Unvested, Beginning balance (in Shares)	57	272
Weighted Average Grant Date Fair Value, Beginning balance	$ 14.57	$ 58
Aggregate Intrinsic Value, Beginning balance	$ 318.63	$ 4,890
Unvested, Granted (in Shares)	163	170
Weighted Average Grant Date Fair Value, Granted	$ 4.82	$ 16.05
Aggregate Intrinsic Value, Granted
Unvested, Vested (in Shares)	(180)	(327)
Weighted Average Grant Date Fair Value, Vested	$ 6.83	$ 48.2
Aggregate Intrinsic Value, Vested
Unvested, Cancelled/Forfeited (in Shares)		(58)
Weighted Average Grant Date Fair Value, Cancelled/Forfeited		$ (37)
Weighted Average Grant Date Fair Value, Cancelled/Forfeited		$ 37
Aggregate Intrinsic Value, Cancelled/Forfeited
Unvested Ending balance (in Shares)	40	57
Weighted Average Grant Date Fair Value, Ending balance	$ 9.67	$ 14.57
Aggregate Intrinsic Value, Ending balance	$ 89.6	$ 318.63
Performance Shares [Member]
Stockholders’ Equity (Deficit) (Details) - Schedule of the Status of our Unvested and Related Transactions [Line Items]
Unvested, Beginning balance (in Shares)	19	164
Weighted Average Grant Date Fair Value, Beginning balance	$ 52.15	$ 51.5
Aggregate Intrinsic Value, Beginning balance	$ 107.55	$ 2,953
Unvested, Granted (in Shares)		63
Weighted Average Grant Date Fair Value, Granted		$ 34.5
Aggregate Intrinsic Value, Granted
Unvested, Vested (in Shares)	(5)	(133)
Weighted Average Grant Date Fair Value, Vested	$ 56.05	$ 47.12
Aggregate Intrinsic Value, Vested	$ (10.72)	$ (2,382.98)
Unvested, Cancelled/Forfeited (in Shares)		(75)
Weighted Average Grant Date Fair Value, Cancelled/Forfeited		$ (44.85)
Weighted Average Grant Date Fair Value, Cancelled/Forfeited		$ 44.85
Aggregate Intrinsic Value, Cancelled/Forfeited
Unvested Ending balance (in Shares)	14	19
Weighted Average Grant Date Fair Value, Ending balance	$ 50.87	$ 52.15
Aggregate Intrinsic Value, Ending balance	$ 33	$ 107.55